scholarly journals “Is that for here or to go?” Drive Through Pediatric Vaccine Clinic as a Novel Approach during a global pandemic

Author(s):  
Sowmya Patil ◽  
Karalyn Kerby ◽  
Amy Ramick ◽  
Justin H. Criddle

ABSTRACT Objective: Routine childhood vaccination and well-child visits are essential for pediatric patients’ preventative and public healthcare services. The COVID-19 pandemic had an immediate and significant decline in well-child visits and vaccine administration. A one-of-a-kind’ Drive Through Vaccine Clinic’ was established to improve the vaccination rate and alleviate parental anxiety about being exposed to COVID-19 infection. Methods: Our initial focus was on children between 18 months – 4 years of age at the start of the pandemic, and then slowly extended this to the back-to-school vaccines and the Influenza vaccines. Results: The Drive-Through Immunization Station provided 745 vaccines to 415 patients between April and September 2020. The median wait time involved from patient arrival to completion of vaccine administration was five minutes at the Drive-Through location. Patient and parent feedback was positive. The addition of Drive Through Clinic helped significantly increase the total number of vaccines administered compared to the previous year. Conclusion: In a global pandemic, innovative ideas to increase access to preventive healthcare should be a priority. In the future, this method of nontraditional vaccine administration will allow for improved outreach efforts to underserved populations in our communities and better disaster preparedness.

Author(s):  
Jose Antonio Vazquez-Ibarra ◽  
Rodolfo Rafael Medina-Ramirez ◽  
Irma Jimenez-Saucedo

Public healthcare services face a growing demand and Emergency department is the main entrance to these services. Waiting times at Emergency departments are increasing at risky levels, causing that people die in wait rooms due to a lack of staff to serve timely every patient. Present chapter describes one research project conducted in a mexican public hospital which was in the process of adopting a triage systems in order to reach the goal of a maximum wait time in department. Design of experiments is the tool proposed to analyze waiting time factors and define the best levels to reduce the response variable value.


Author(s):  
Jose Antonio Vazquez-Ibarra ◽  
Rodolfo Rafael Medina-Ramirez ◽  
Irma Jimenez-Saucedo

Public healthcare services face a growing demand and Emergency department is the main entrance to these services. Waiting times at Emergency departments are increasing at risky levels, causing that people die in wait rooms due to a lack of staff to serve timely every patient. Present chapter describes one research project conducted in a mexican public hospital which was in the process of adopting a triage systems in order to reach the goal of a maximum wait time in department. Design of experiments is the tool proposed to analyze waiting time factors and define the best levels to reduce the response variable value.


2021 ◽  
pp. 114280
Author(s):  
Fadhila Mazanderani ◽  
Susan F. Kirkpatrick ◽  
Sue Ziebland ◽  
Louise Locock ◽  
John Powell

2021 ◽  
Author(s):  
Hsiu An Lee ◽  
Hsin-Hua Kung ◽  
Wei-Chen Wu ◽  
Jai Ganesh Udayasankaran ◽  
Yu-Chih Wei ◽  
...  

BACKGROUND The coronavirus disease 2019 (COVID-19) is an ongoing global pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). The prevention and treatment methods for COVID-19 are not yet clear. At present, there are at least 287 preventive vaccines against COVID-19 in the world, of which 5 vaccines are available for emergency use as of June 2021, but none has completed clinical trial. Nevertheless, with the development of vaccines, disease conditions in various countries are gradually controlled. OBJECTIVE The vaccination rate has increased in time, and activities in various countries have gradually recovered. Therefore, the focus of the next stage is confirming and proving that everyone is vaccinated to ensure that those without vaccines will not become a breach in the next wave of diseases. The vaccination or RT-PCR test results are all certified and verified by paper documents issued by hospitals or testing institutions. Meanwhile, falsified documents are a major risk factor in confirming the vaccination status and laboratory test results. Although the Vaccine Passport (VP) may become an important key to future global activities based on the current strategy, the problems of document verification and data use among countries have not yet been resolved. METHODS The blockchain architecture proposed in this research can be applied together by public and private entities and be rapidly expanded. Furthermore, the open ledger of blockchain achieves transparency and data accuracy. On the other hand, smart contracts (SCs) achieve authorization and authentication, while the encryption and decryption mechanisms achieve data protection. In order to make it globally available, the international data standard “Fast Healthcare Interoperability Resource (FHIR)” is adopted into this research. In general, this blockchain architecture can achieve global vaccine passport verification accurately and at a low cost. RESULTS The open nature of the blockchain contributes to establishing transparency and data accuracy. Total three entities are included in this blockchain architecture. All of the authorization are public in the open ledger. The smart certificate enables authorization and authentication, while the encryption and decryption mechanism ensure data protection. This proof of concept demonstrates the design of blockchain architecture which, when adopted, can achieve global vaccine passport verification accurately and at a cost country can afford. An actual vaccine passport case was established and demonstrated in this study. Open blockchain, individually authorized authentication mechanisms, and international standard vaccine passports were adopted. CONCLUSIONS Blockchain architecture is used to build the authentication process of an executable international vaccine passport, with advantages of low cost, high interoperability, effectiveness, security and verifiability.


2008 ◽  
Vol 57 (3) ◽  
pp. 529-560 ◽  
Author(s):  
Adam Cygan

AbstractThis article examines how recent judgments of the European Court of Justice have interpreted the concept of a service of general interest in Article 86(2) EC in the delivery of healthcare services. The article explores how and why the Court has afforded greater latitude to Member States in organizational matters by not applying competition rules. By contrast, the Court has actively promoted patient mobility and has not applied the derogation in Article 86(2) EC where it would restrict the free movement of services. Does the Court's policy of protecting individual rights undermine the ability of Member States to deliver a universal healthcare service within finite resources?


2016 ◽  
Vol 32 (suppl 2) ◽  
Author(s):  
Laís Silveira Costa

Abstract: The contemporary context of population aging, itsthe population's different health and disease characteristics, and the growing incorporation of technologies by healthcare systems have highlighted the need to adjust the healthcare structure as a whole. The defense of a democratic and sustainable system reveals the importance of understanding how changes in healthcare take place. The current article aims to contribute to the understanding of innovation in healthcare services. The study's results indicate that the existence of certain knowledge gaps means that public policies tend to overlook a whole rangeseries of innovations normally associated with social changes, with a consequentwith an impact on human development, social cohesion, equality, and equity, allcentral issues that are central toin the field of collective public healthcare field. The article concludes that the lack of a mature theoretical framework negatively impacts the formulation of such policies, further aggravated in Brazil by growing differences in quality and access between population segments that depend on the public and private healthcare systems.


Biosensors ◽  
2021 ◽  
Vol 12 (1) ◽  
pp. 11
Author(s):  
Zhijian Yi ◽  
Jean de Dieu Habimana ◽  
Omar Mukama ◽  
Zhiyuan Li ◽  
Nelson Odiwuor ◽  
...  

Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has led to a global pandemic with a high spread rate and pathogenicity. Thus, with limited testing solutions, it is imperative to develop early-stage diagnostics for rapid and accurate detection of SARS-CoV-2 to contain the rapid transmission of the ongoing COVID-19 pandemic. In this regard, there remains little knowledge about the integration of the CRISPR collateral cleavage mechanism in the lateral flow assay and fluorophotometer. In the current study, we demonstrate a CRISPR/Cas12a-based collateral cleavage method for COVID-19 diagnosis using the Cas12a/crRNA complex for target recognition, reverse transcription loop-mediated isothermal amplification (RT-LAMP) for sensitivity enhancement, and a novel DNA capture probe-based lateral flow strip (LFS) or real-time fluorescence detector as the parallel system readout facility, termed CRICOLAP. Our novel approach uses a customized reporter that hybridizes an optimized complementary capture probe fixed at the test line for naked-eye result readout. The CRICOLAP system achieved ultra-sensitivity of 1 copy/µL in ~32 min by portable real-time fluorescence detection and ~60 min by LFS. Furthermore, CRICOLAP validation using 60 clinical nasopharyngeal samples previously verified with a commercial RT-PCR kit showed 97.5% and 100% sensitivity for S and N genes, respectively, and 100% specificity for both genes of SARS-CoV-2. CRICOLAP advances the CRISPR/Cas12a collateral cleavage result readout in the lateral flow assay and fluorophotometer, and it can be an alternative method for the decentralized field-deployable diagnosis of COVID-19 in remote and limited-resource locations.


2021 ◽  
Author(s):  
Gunnar Ellingsen ◽  
Bente Christensen ◽  
Morten Hertzum

Large-scale electronic health record (EHR) suites have the potential to cover a broad range of use needs across various healthcare domains. However, a challenge that must be solved is the distributed governance structure of public healthcare: Regional health authorities regulate hospitals, municipalities are responsible for first-line healthcare services, and general practitioners (GPs) have an independent entrepreneurial role. In such settings, EHR program owners cannot enforce municipalities and GPs to come on board. Thus, we examine what tactics owners of large-scale EHR suite programs apply to persuade municipalities to participate, how strongly these tactics are enforced, and the consequences. Empirically, we focus on the Health Platform program in Central Norway where the goal is to implement the U.S. Epic EHR suite in 2022. Theoretically, the paper is positioned in the socio-technical literature.


Sign in / Sign up

Export Citation Format

Share Document